Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
In Vivo ; 1(4): 229-34, 1987.
Artigo em Inglês | MEDLINE | ID: mdl-2979788

RESUMO

Ten new Pt (II) complexes were synthesized and tested as potential antitumor drugs in vitro on KB human tumour cell line, and in vivo against four experimental tumour systems (P388, L1210, ADJ/PC6A and Yoshida sarcoma). The complexes contained two primary amine ligands (cyclopentylamine) with bidentate leaving ligands consisting of nitro-, dinitro- and sulfo-derivatives of phthalic and isophthalic anions. Various complexes showed a good cytostatic effect in vitro with ID50 from 0.29 and 0.99 mcg/ml. The Pt(cpa)2 (5-sulfo-IPA) appeared to be the most effective compound against P388 and L1210 (T/C% 310 and 250 respectively after three 50 mg/Kg i.p. injections) as well as against ADJ/PC6A (ID90 2.8 mg/kg after a single i.p. injection) and Yoshida sarcoma (T/C% 17.5 after a single 50 mg/kg i.p. injection), but the phthalic acid nitro-derivatives were also quite effective. As far as antileukemic effect was concerned, there was a fairly good correlation between the results in vitro and in vivo. Relationships between antitumour activity and pi electronic charge localization on O- atoms of leaving ligands (M.O. Huckel's Calculations) are also discussed.


Assuntos
Antineoplásicos/uso terapêutico , Leucemia Experimental/tratamento farmacológico , Neoplasias Experimentais/tratamento farmacológico , Platina/uso terapêutico , Sarcoma Experimental/tratamento farmacológico , Animais , Antineoplásicos/síntese química , Antineoplásicos/farmacologia , Divisão Celular/efeitos dos fármacos , Linhagem Celular , Sobrevivência Celular/efeitos dos fármacos , Ciclopentanos , Camundongos , Platina/farmacologia
3.
Arzneimittelforschung ; 40(2 Pt 1): 183-7, 1990 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-2334458

RESUMO

Six new platinum (II)-sulfonamide complexes were examined for their in vitro cytostatic properties as well as in vivo antitumour effect against three experimental murine tumours. The possible antitrypanosomic in vivo activity against T. brucei, T. congolense and T. cruzi infections was also evaluated. The synthesis and chemical characterization of new complexes is reported. Only two sulfadiazine derivatives appeared to be effective mainly against Ehrlich ascites but in a smaller extent than cisplatin. A satisfactory correlation between antitumour and antitrypanosomic activity was found.


Assuntos
Antineoplásicos/síntese química , Compostos Organoplatínicos/síntese química , Sulfonamidas/síntese química , Tripanossomicidas/síntese química , Animais , Carcinoma de Ehrlich/tratamento farmacológico , Nefropatias/induzido quimicamente , Leucemia P388/tratamento farmacológico , Masculino , Camundongos , Compostos Organoplatínicos/farmacologia , Compostos Organoplatínicos/toxicidade , Ratos , Ratos Endogâmicos , Sarcoma 180/tratamento farmacológico , Espectrofotometria Infravermelho , Sulfonamidas/farmacologia , Sulfonamidas/toxicidade , Tripanossomíase/tratamento farmacológico
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa